Intraductal carcinoma associated with invasive carcinoma of the breast: A comparison of the two lesions with implications for intraductal carcinoma classification systems

American Journal of Clinical Pathology

Volumn 106, Issue 3, 1996, Pages 312-318

  Goldstein, Neal S ^a   Murphy, Tracy ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast; Duct carcinoma in situ; Invasive carcinoma

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CELL NUCLEUS; CYTOARCHITECTURE; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL;

EID: 0029739001     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.3.312     Document Type: Article

References (40)

1. Moriya T, Silverberg SG. Intraductal carcinoma (ductal carcinoma in situ) of the breast: A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma. Cancer 1994;74:2792-2798.
2. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: Correlation of the histologic type of the in situ component with grade of the infiltrating component. Sem Diag Pathol 1994;11:215-222.
3. Enjoji M, Toyoshima S. Ductal carcinoma of the breast: An analysis of proportions of intraductal and invasive carcinoma. Path Res Pract 1991;187:62-67.
4. Lagios MD, Margilin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade in local recurrence. Cancer 1989;63:618-624.
5. Patchefsky AS, Schwartz GF, Finkelstein SD, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63:731-741.
6. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast: Heterogeneity of individual lesions. Cancer 1994;73:118-124.
7. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-1319.
8. Page DL, Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial: Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer 1995;75:1219-1222.
9. Fisher ER, Costantino J, Fisher B, Palekar AS, Mamounas E. Response-Blunting the counterpoint. Cancer 1995;75:1223-1227.
10. Lagios MD. Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment. The Breast Journal 1995;1:68-78.
11. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 1987.
12. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
13. Fechner RE. One century of mammary carcinoma in situ: What have we learned? Am J Clin Pathol 1993;100:654-661.
14. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment. Cancer 1993;71:2532-2542.
15. Poller DN, Silverstein MJ, Galea M, et al. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994;7:257-262.
16. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast: Short-term results of a prospective nationwide study. Am J Surg Pathol 1992;16:1183-1196.
17. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Hum Pathol 1993;24:16-23.
18. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated by biopsy only. Cancer 1995;76:1197-1200.
19. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50: 1309-1314.
20. Boyages J, Recht A, Connolly J, et al. Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990;19:29-41.
21. Jacquemier J, Kurtz J, Amalric R, et al. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer 1990;61:873-876.
22. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719-725.
23. Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol 1994;12:653-660.
24. Schnitt SJ, Connolly J, Khettry U, et al. Pathologic findings on reexcision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 1987;59: 675-681.
25. Holland R, Connolly J, Gelman R. et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-118.
26. Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS. Ductal carcinoma in situ of the breast: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erb-B-2 protein. Cancer 1995;75:2123-2131.
27. Wilber DC, Barrows GH. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: An immunohistochemical study. Mod Pathol 1993;6:114-120.
28. Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 1992;69:1174-1181.
29. Lodato RF, Maguire HC, Greene MI, Weiner DB, LiVolsi VA. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol 1990;3:449-454.
30. Schimmelpenning H, Eriksson ET, Pallis L, et al. Immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human mammary carcinoma in situ. Am J Clin Pathol 1992;97(suppl 1):S48-S52.
31. Killeen JL, Namiki H. DNA analysis of ductal carcinoma in situ of the breast. Cancer 1991;68:2602-2607.
32. Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA. Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma: A detailed morphological analysis. J Pathol 1990;161:7-14.
33. Zifrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: Correlation with estrogen and progesterone receptors, p53, and c-erbB-2 proteins, and proliferative activity. Sem Diag Pathol 1994;11:208-214.
34. De Potter CR, Schelfhout A, Verbeeck P, et al. Neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast. Hum Pathol 1995;26:601-606.
35. Fisher ER, Siderits R. Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Breast Cancer Res Treat 1992;21:165-172.
36. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Sem Diag Pathol 1994;11:223-235.
37. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995;345: 1154-1157.
38. Sneige N, McNeese MD, Atkinson EN, et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathological analysis of 49 specimens with emphasis on risk factors and long-term results. Hum Pathol 1995;26:642-649.
39. Rosen PP, Oberman HA. Intraepithelial (preinvasive or in situ) carcinoma. In: Atlas of Tumor Pathology, ed 3. Washington, DC: Armed Forces Institute of Pathology Press, 1993, pp 119-156.
40. Holland R, Peterse J, Millis RR, et al. Ductal carcinoma in situ: A proposal for a new classification. Sem Diag Pathol 1994;11: 167-180.